Figure 1. Overview of host pathways and viral replication mechanisms of the repurposed therapeutic drugs undergoing clinical trial against COVID-19.
Drugs of both biological and chemical origins are shown along with a number of vaccines involved in repurposed applications in context of their respective pathways and mechanisms.